title: Decreased function of Fas in patients displaying delayed progression of HIV-induced immune deficiency.
abstract: BACKGROUND
  In acquired immune deficiency syndrome patients, apoptosis of uninfected lymphocytes may contribute to development of immune deficiency. This process may involve recruitment of Fas by human immunodeficiency virus products. In line with this possibility, the viral envelope glycoprotein gp120 does not induce death of T cells from subjects with the autoimmune/lymphoproliferative syndrome displaying defective Fas function. This study evaluates the possibility that Fas function defects delay progression of HIV-induced immune deficiency.
  
  
  METHODS
  The susceptibility to Fas-induced cell death was assessed on T cells from 18 'long-term non-progressor', four 'non-progressor', four 'progressor' asymptomatic HIV-1-infected, and nine AIDS patients using anti-Fas monoclonal antibodies.
  
  
  RESULTS
  Fas-induced cell death was significantly lower in long-term non-progressors and non-progressors than in normal controls, progressors, and AIDS. The single-patient data showed that 9/18 long-term non-progressors and 3/4 non-progressors, but no progressors or AIDS were resistant to Fas. Analysis of the uninfected parents of two long-term non-progressors displaying decreased Fas-function showed that the mother of one of them and the father of the other displayed the same Fas function defect as their children. Fusion of T cells from Fas-resistant individuals with a Fas-sensitive cell line gave rise to Fas-resistant hybrid lines not carrying HIV, which suggests that the resistant phenotype is due to molecules exerting a dominant negative effect on a normal Fas system.
  
  
  CONCLUSIONS
  These data suggest that Fas-resistance in long-term non-progressors may be due to inherited alterations of the Fas signaling pathway and may be a novel factor in delayed progression.
authors.affiliation: Department of Medical Science, 'A. Avogadro' University of Eastern Piedmont, 28100 Novara, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Bottarel
authors.forename: S
authors.initials: S
authors.lastname: Bonissoni
authors.forename: M B
authors.initials: MB
authors.lastname: Lucia
authors.forename: M
authors.initials: M
authors.lastname: Bragardo
authors.forename: T
authors.initials: T
authors.lastname: Bensi
authors.forename: D
authors.initials: D
authors.lastname: Buonfiglio
authors.forename: C
authors.initials: C
authors.lastname: Mezzatesta
authors.forename: D
authors.initials: D
authors.lastname: DiFranco
authors.forename: C
authors.initials: C
authors.lastname: Balotta
authors.forename: M R
authors.initials: MR
authors.lastname: Capobianchi
authors.forename: I
authors.initials: I
authors.lastname: Dianzani
authors.forename: R
authors.initials: R
authors.lastname: Cauda
authors.forename: U
authors.initials: U
authors.lastname: Dianzani
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis* / Q000235:genetics; D000911:Antibodies, Monoclonal; D017209:Apoptosis / Q000235:genetics / Q000502:physiology; D016022:Case-Control Studies; D018450:Disease Progression; D005192:Family Health; D020276:HIV Long-Term Survivors; D006801:Humans; D011379:Prognosis; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology; D013601:T-Lymphocytes / Q000378:metabolism / Q000502:physiology / Q000821:virology; D019014:fas Receptor / Q000235:genetics / Q000276:immunology / Q000502:physiology*
chemical_list: D000911:Antibodies, Monoclonal; D019014:fas Receptor